Robin/openwiki-wiki
1
0
Fork 0
Code Issues Pull Requests Actions Packages Projects Releases Wiki Activity

chore: daily update 2026-07-29

Browse Source
This commit is contained in:
OpenWiki Bot
2026-07-29 02:12:55 +08:00
parent fa3c82079f
commit 61cd78a06a
8 changed files with 184 additions and 42 deletions
Download Patch File Download Diff File Expand all files Collapse all files
sources/web-search.md
+52 -1
View File
@@ -172,5 +172,56 @@ All three items fold into the existing `class-organoid-3d-bioprinting` row. Last
- Pull 2: fetched 2026-07-26T18:07:27Z — raw `~/.openwiki/connectors/web-search/raw/2026-07-26T18-07-14-335Z/web-search-results.json`
- Pull 3: fetched 2026-07-26T18:16:21Z — raw `~/.openwiki/connectors/web-search/raw/2026-07-26T18-16-06-804Z/web-search-results.json`
- Pull 4: fetched 2026-07-27T18:04:46Z — raw `~/.openwiki/connectors/web-search/raw/2026-07-27T18-04-01-259Z/web-search-results.json`
- Queries: pulls 1, 2, 4 = 10 queries each; pull 3 = 6 queries (vendor-anchored only)
- Pull 5: fetched 2026-07-28T18:04:26Z — raw `~/.openwiki/connectors/web-search/raw/2026-07-28T18-03-43-560Z/web-search-results.json`
- Queries: pulls 1, 2, 4, 5 = 10 queries each; pull 3 = 6 queries (vendor-anchored only)
- Instance: `web-search-1`
---
## 2026-07-28 18:04 pull
Fifth Tavily pull, run as a stand-alone `openwiki personal --update` source ingest. All 10 queries re-run. Two lanes produced genuinely new material evidence (China Order No. 818 regulatory shift; LLM Wiki + OKF shared-memory architecture cluster). The China CDE classification item, CelVivo/TheWell partnership, and Hermes v0.19 Quicksilver rows were not re-anchored in this pull — they remain pinned via `/commitments.md` and the `hermes-agent-v0-19-quicksilver` / `china-cde-cell-gene-therapy-rules-2026` theme rows. Tavily answer-text mis-attribution continues on the 3Brain, Cellink, and Hermes lanes.
### China Order No. 818 — accelerated clinical-translation pathway — source-backed
This is a **new Chinese regulatory signal distinct from the existing CDE classification item**. Order No. 818 (effective 2026-05-01) creates an accelerated pathway for advanced biomedical technologies — including cell therapy and 3D bioprinting — to reach clinical translation at qualified hospitals after demonstrating safety and preliminary efficacy.
- **LinkedIn (BetaLife SG), 2026-07:** [#ipsc #betalife #celltherapy #ipsc #regenerativemedicine #diabetes #clinicaltranslation #biotechnology #xiamen](https://www.linkedin.com/posts/betalife-sg_betalife-celltherapy-ipsc-activity-7487455334345834497-5hKR). Score 0.779. Explicitly references "Order No. 818, effective May 1, 2026. The regulation introduces an accelerated pathway for eligible advanced biomedical technologies towards regulated clinical translation at qualified hospitals after demonstrating safety and preliminary efficacy." BetaLife (a Singapore-based iPSC company) names this in their post; they cite it as directly relevant to their China clinical-translation journey.
- **Roots Analysis, 2026-07:** [Cell Therapy Manufacturing Market Size 2035](https://www.rootsanalysis.com/reports/cell-therapy-manufacturing/285.html). Score 0.669. Re-mention of the broader China cell-therapy regulatory landscape (Merck–Bio-Techne $11.3B acquisition, CARsgen China approval). Not an Order No. 818 citation directly, but corroborates the pattern of accelerating China cell-therapy regulatory activity in the same window.
- **Tavily answer text** independently synthesizes: "China's regulation under Order No. 818, effective May 1, 2026, introduces an accelerated pathway for advanced biomedical technologies, including cell therapy and 3D bioprinting, towards clinical translation at qualified hospitals after demonstrating safety and preliminary efficacy." This is the same content as the BetaLife post — single primary source, with Tavily's synthesis echoing it.
**Robin relevance:** HIGH for the Chinese pharma R&D / CDMO / biotech customer base. Order No. 818 is the **clinical-translation pathway** counterpart to the CDE classification item (which is about CMC planning). Both items matter: classification scope drives what dossier content vendors need to assemble, and the clinical-translation pathway drives which hospitals can host the first-in-human studies. Together they shape how Femtobiomed positions CelVivo-class bioreactors and 3Brain-class MEA platforms into Chinese accounts.
**Why source-backed (not watchlist):** the item is published regulatory text (Order No. 818, effective 2026-05-01), not a rumor; BetaLife is a credible industry-actor source citing it in their own clinical-translation context; the Tavily synthesis is consistent with the BetaLife wording. Treat as source-backed pending direct NMPA / State Council corroboration. **Promoted** to `/themes.md` as a new row `china-order-no-818-clinical-translation` and to `/commitments.md` as a verification item.
### LLM Wiki + OKF / shared-agent-memory cluster — source-backed (workflow tooling, low priority)
The `agent personal memory wiki 2026` query returned five same-week sources on a single coherent architecture: a shared agent-memory layer using Andrej Karpathy's LLM Wiki + Google's Open Knowledge Format (OKF) + Model Context Protocol (MCP), positioned to let "every Local AI … share ONE permanent memory." This is directly adjacent to OpenWiki's role.
- **YouTube (Kai), 2026-07-23:** [LLM Wiki + OKF Every Local AI Now Shares ONE Memory](https://www.youtube.com/watch?v=9ciGYHHOLyU). Score 0.752. Walkthrough of the LLM Wiki + OKF + MCP stack for cross-agent shared memory without vector databases.
- **Taskade AI, 2026-07:** [The 4 Types of AI Agent Memory Explained (2026)](https://www.taskade.com/wiki/ai-agents/memory-types). Score 0.705. Taskade's own memory architecture (long-term / episodic / short-term / semantic) framed in the same shared-memory terms.
- **GitHub (SamurAIGPT), 2026-07:** [SamurAIGPT/llm-wiki-agent](https://github.com/SamurAIGPT/llm-wiki-agent). Score 0.694. Open-source "personal knowledge base that builds and maintains itself" — wiki-ingest / wiki-query primitives that mirror Robin's OpenWiki mental model.
- **LinkedIn (David Bressler, PhD), 2026-07:** [Personal wikis, LLM-maintained knowledge bases, and agent memory systems all eventually hit the same question: How do you know the information in there is still accurate?](https://www.linkedin.com/posts/david-bressler_personal-wikis-llm-maintained-knowledge-activity-7486993623939678208-q4rL). Score 0.614. Adjacent commentary on knowledge-base freshness in agent-maintained wikis.
- **Reddit r/ClaudeAI, 2026-07-23:** [How many of you are running an LLM wiki with claude code?](https://www.reddit.com/r/ClaudeAI/comments/1v4rdiv/how_many_of_you_are_running_an_llm_wiki_with). Score 0.288 (31 upvotes, 26 comments). Community confirmation that OKF-formatted Obsidian wikis are a working pattern for Claude Code users.
- **BigDATAwire (Exabase), 2026-07-28:** [Exabase Reports State-of-the-Art Results on BEAM Memory Benchmark](https://www.hpcwire.com/bigdatawire/this-just-in/exabase-reports-state-of-the-art-results-on-beam-memory-benchmark). Score 0.567. Adjacent: BEAM-style memory benchmarks for agent memory engines.
**Robin relevance:** workflow-tooling, low priority — but the cluster is **substantially more corroborated than the prior HN-only signal**. Five distinct publishers (YouTube creator, SaaS vendor, GitHub, LinkedIn, Reddit) and one adjacent benchmark in the same week all converge on the same OKF + MCP shared-memory architecture. Combined with the existing `agent-memory-architecture` row's three HN Show HN items, the topic now has 8+ distinct sources. **Promote** `agent-memory-architecture` from `watchlist` to `source-backed` and refresh Last seen to 2026-07-28.
### 3Brain / Cellink / CellShot / installed-base / Hermes lanes — no new vendor-anchored evidence; Tavily answer-text mis-attribution recurs
- **3Brain CorePlate MEA 2026:** the Nature [portable semi-dry EEG device paper](https://www.nature.com/articles/s41598-026-52672-8) reappears at score 0.187. Tavily answer text again labels it "3Brain CorePlate MEA 2026 validated in a brain–computer interface study" — the underlying paper is about a portable EEG headset, **not 3Brain's MEA chips**. This is the fourth pull in a row with the same mis-attribution. Do not promote as 3Brain evidence.
- **Cellink BIO X bioprinter 2026:** Tavily answer text labels the Roche [ADLM 2026 intelligent lab solutions press release](https://www.biospace.com/press-releases/roche-showcases-intelligent-lab-solutions-and-high-precision-instruments-at-adlm-2026-to-help-laboratories-address-workforce-and-workflow-challenges) (0.082) as "Cellink BIO X bioprinter at ADLM 2026" — the underlying source is Roche, not Cellink. The remainder of the lane is industry context (Nova Biomedical–NanoCellect, Massive Bio–GELL, Lumafield Mars X-ray, Repligen–BioLife, BioTechniques bi-weekly). All unrelated to Cellink BIO X / BIONOVA X / Lumen X.
- **CellShot / CellPick bioprinter 2026:** Tavily honestly says "the CellShot CellPick bioprinter 2026 is not directly mentioned in the provided data sources." Top hits are CCDx whole-cell genomic profiling (0.164), Nova Biomedical–NanoCellect (0.062), AI protein engineering model (0.059), Towards Healthcare cell-and-gene-therapy intelligence infrastructure (0.052), Pluristyx re-mention (0.042). No Femtobiomed vendor signal.
- **labs CelVivo ClinoStar installed base 2026:** no direct result. Cepheid GeneXpert third-generation ADLM 2026 (score 0.112) and Roche ADLM 2026 (0.143) dominate the top slots and are unrelated to CelVivo installed-base. Query phrasing continues to drift toward competitor/molecular-diagnostic content.
- **Hermes Agent MiniMax M3 changelog 2026:** Tavily answer text returns Apple product news ("Mismatched M6 and M5 Pro chips", iOS 26.6, POCO Launcher 7.50) — no Hermes Agent, no MiniMax M3, no Hermes changelog in the underlying URLs. Top hit: [MacRumors Next Mac Mini article](https://www.macrumors.com/2026/07/22/mac-mini-m6-m5-pro-chips-rumor/) at 0.074. The v0.19 Quicksilver signal from the prior pull remains the most recent Hermes row; this lane produced nothing new in this 24h window.
- **OpenWiki connectors Tavily RAGFlow 2026:** Tavily recall still broken. Returns AWWA ACE26 SmartBall X (0.025), Bizora advisory group / Billtrust MCP server (0.026), OpenTug shipping (0.017), Sunvega AI spatial-design workspace (0.016), RightShip maritime (0.016), Inland Tank-Barge Safety Guide (0.015). Only the Billtrust MCP server item is mildly adjacent (MCP-server ecosystem); the rest is unrelated to OpenWiki / Gitea / Wiki.js / RAGFlow / NocoDB / SeaFile. Recommend dropping this lane from future Tavily runs unless the query is rephrased to anchor on product names.
- **organ-on-chip pharma collaboration 2026:** the Nature [Gut-on-a-Chip culturomics paper](https://www.nature.com/articles/s44385-026-00099-1) (0.986) is the same item surfaced in the 2026-07-26 17:39 pull. Application-domain signal only — folds into the `class-organoid-3d-bioprinting` row without a new evidence note.
### Synthesis result
- **Two new scope-aligned findings:**
1. **China Order No. 818** — clinical-translation pathway for cell therapy + 3D bioprinting at qualified hospitals, effective 2026-05-01. Source-backed on a single primary source (BetaLife LinkedIn) with Tavily synthesis corroboration. Distinct from the existing `china-cde-cell-gene-therapy-rules-2026` item (classification vs clinical pathway). Promoted to `/themes.md` as new row `china-order-no-818-clinical-translation` and to `/commitments.md` as a verification item.
2. **LLM Wiki + OKF shared-memory cluster** — five Tavily sources + three prior HN sources all converge on Karpathy's LLM Wiki + Google OKF + MCP shared-memory architecture. Directly adjacent to OpenWiki's role. Promotes existing `agent-memory-architecture` row from `watchlist` to `source-backed`.
- **No new vendor-anchored evidence** on CelVivo, 3Brain, Cellink, CellShot/TriArm, or Hermes this pull. The prior vendor-anchored items (CelVivo+TheWell, Hermes v0.19 Quicksilver) remain on disk and referenceable; the Hermes row's Last seen is **not** refreshed because the underlying URLs in this pull returned Apple-product noise.
- **Tavily answer-text mis-attribution pattern persists** on 3Brain (4th pull), Cellink (4th pull), and Hermes (1st pull). This is a Tavily-side quality issue; treat Tavily answer text as untrusted and only the underlying URLs as evidence. Continued recommendation: narrow future pulls to vendor-name-anchored queries only.
- **OpenWiki / RAGFlow / agent-memory lane behavior changed.** The lane still produces zero OpenWiki/RAGFlow/SeaFile/NocoDB/Gitea results, but the **agent-personal-memory-wiki** lane is now high-signal for the OKF/LLM Wiki architecture — strong enough to promote the existing `agent-memory-architecture` row.